Long Ideas - SciClone Pharmaceuticals (NASDAQ:SCLN) announced Tuesday morning that, as expected, the Chinese government has reduced the list price for Zadaxin. This action has been expected for … Continue Reading
Read nowMost Popular - Shares of Navidea Biopharmaceuticals (NASDAQ:NAVB) are trading up 9% Monday on optimism over a quick resubmission of information in support of Lymphoseek’ approval following a … Continue Reading
Read nowQuick Picks - Targacept (NASDAQ:TRGT) announced Monday morning that its Phase II trial for TC-5619 in the treatment of inattentive-predominant attention deficit/hyperactivity disorder (ADHDi) did not meet its … Continue Reading
Read nowMost Popular - Complete Genomics (NASDAQ:GNOM) announced that it has reached buy-out terms with Chinese pharmaceutical company BGI-Shenzhen, in which GNOM will be sold for $117.6M, or $3.15/share. … Continue Reading
Read nowLong Ideas - Vivus (NASDAQ:VVUS) released Monday morning that Qsymia is now commercially available as an aid for weight loss. VVUS had guided for a 4Q 2012 launch … Continue Reading
Read nowLong Ideas - Reports from Bloomberg that Amarin Corp. (NASDAQ:AMRN) has pulled out of the UBS Global Life Sciences Conference next week is leading some analysts to the … Continue Reading
Read now- After publishing an update on on the company’s lead product, H.P. Acthar Gel, shares of Questcor Pharmaceuticals (NASDAQ:QCOR) were up 6% in early trading on … Continue Reading
Read now